Dianthus Therapeutics | MGTA - Trade Debtors

Stock Price
49.93
Daily Change
3.35 7.19%
Monthly
31.08%
Yearly
116.62%
Q1 Forecast
51.75

Dianthus Therapeutics reported $5M in Trade Debtors for its fiscal quarter ending in September of 2025.





Trade Debtors Change Date
Alaunos Therapeutics USD 2K 0 Jun/2025
Avita Medical AUD 11.37M 593K Jun/2025
Celltrion KRW 1.51T 128.69B Sep/2025
Cspc Pharmaceutical CNY 8.85B 769.12M Jun/2025
Dianthus Therapeutics USD 5M 4.96M Sep/2025
Divis Laboratories Ltd INR 26.28B 1.16B Sep/2025
IQVIA Holdings USD 3.43B 113M Dec/2025
Kangmei Pharma CNY 3.15B 295.48M Sep/2025
Knight Therapeutics CAD 103M 8.1M Sep/2024
Laboratorios Farma EUR 143.38M 16.93M Dec/2023
Malin Corporation EUR 500K 300K Dec/2024
Medical Developments International AUD 7.65M 162K Jun/2025
Moderna USD 1.05B 589M Sep/2025
Neuren Pharmaceuticals AUD 20.71M 155.01M Jun/2025
Organigram Holdings CAD 64.86M 7.31M Sep/2025
Organon & Co USD 1.48B 0 Sep/2025
Pharma Mar EUR 41.76M 26.1M Sep/2025
Qiagen NV USD 393.56M 7.8M Sep/2025
Revvity USD 680.26M 19.12M Sep/2025
Sartorius EUR 344.7M 48.5M Sep/2025
Sino Biopharmaceutical CNY 8.45B 3.18B Jun/2025
Tectonic Therapeutic USD 0 270K Dec/2023
Tilray USD 121.49M 18.12M Mar/2025
Viatris USD 3.37B 225.7M Sep/2025
Xeris Pharmaceuticals USD 53.75M 700K Sep/2025
Zz Pientze Pharmaceu CNY 1.12B 222.78M Sep/2025